Amgen
Headline intensities
Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.
OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.
EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?
PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.
Climate action evidence
11 records · 2 sources- Self-declared (FY2024)40,000 tCO2e
- Traced by Reverberate12,000 tCO2e(30%)
- Gap28,000 tCO2e
It's not uncommon for carbon credits to be retired via a broker (e.g. Climate Impact Partners, ClimeCo, 3Degrees, South Pole) whose name appears in the registry instead of the end-buyer's — meaning the retirement is real but not third-party-retrievable from the buyer's name alone. We also auto-defer retirements below 1,000 tCO2e to focus attribution on material volume; use the request below to investigate sub-threshold or broker-routed retirements for this firm.
- Unclassified12,000 tCO2e(100%)
- · Puro.earth Registry
- · berkeley_voluntary_registry
Strategy & approach
How the firm describes its decarbonisation approach in its own words — alongside the headline numbers above. Self-reported, page-cited.
In 2024, Amgen sourced 90% renewable electricity across its facilities and achieved a 46% reduction in Scope 1+2 absolute carbon emissions (excluding offsets). The new Ohio fully-electric biomanufacturing facility includes an on-site solar array sized to generate 2,038 MWh annually and deliver renewable energy back to the local grid. Aim is for all Amgen facilities, wherever feasible, to procure 100% renewable energy by 2027.
In 2024, Amgen began augmenting its energy efficiency project portfolio with high-quality Scope 1 carbon emission offsets to assist progress toward its 2027 carbon neutrality ambition. Scope 1 emissions in 2024 include 40,000 MT of high-quality carbon offsets. The report frames these as offsets rather than durable removals.
- Amgen Ecovation™ electrified biomanufacturing
New facilities in North Carolina and Ohio were built using the Amgen Ecovation™ approach — flexible modular designs that are faster, lower-cost, and require less energy and water than traditional plants. The Ohio plant is Amgen's first fully electric biomanufacturing site, supporting the 2027 Scope 1+2 carbon neutrality goal.
- Water and waste reduction projects
In 2024 Amgen executed 198,000 CM of water saving projects and over 300 MT of waste reduction projects. Through 2024, achieved 57% of the 2027 40% water reduction target and 66% of the 75% waste reduction target vs a 2019 baseline.
- Commercial fleet electrification
Increased EV adoption to 687 vehicles across the US, EU, Japan, Australia and South Korea, on track toward a corporate-wide goal of 1,800 EVs by 2027 (30% of total fleet vs 2019 baseline). Field-based employees in the US, Japan and EU must select all-electric or hybrid vehicles. Fleet carbon emissions were 33% lower than the 2019 baseline in 2024.
- SBTi Scope 3 supplier engagement (73% by spend)
On track to reach 2027 SBTi Scope 3 supplier target of engaging 73% of suppliers by spend in key categories to support their adoption of science-based targets. Science-based goal setting has also been embedded in Amgen's sourcing criteria.
Targets
Near-term
5 targets| Scope | Base | Target | Reduction | Alignment | Progress | Status |
|---|---|---|---|---|---|---|
| Scope 1 + 2 | — | 2027 | — | 1.5°C | absolute-value target | — |
| Scope 1 + 2Absolute | 2019 | 2027 | −55% | 1.5°C | 56.0% reduction achieved vs 55% target (102% of the way there). Linear pace expects 34.4% by now. −56.0% reductionof −55% target · 102% there | On track |
| Scope 2 | 2019 | 2027 | −1% | 1.5°C | insufficient data | — |
| Scope 2 | 2019 | 2030 | −1% | 1.5°C | insufficient data | — |
| Scope 3 | 2019 | 2027 | −73% | 0.0% reduction achieved vs 73% target (0% of the way there). Linear pace expects 45.6% by now. −0.0% reductionof −73% target · 0% there | Off track |
Net zero
1 target| Scope | Base | Target | Reduction | Alignment | Progress | Status |
|---|---|---|---|---|---|---|
| Scope 1 + 2 + 3 | — | 2027 | — | In corporate strategy | absolute-value target | — |
⚠ Some targets show progress vs the earliest extracted year as a baseline approximation. The real base-year value will be used once historical reports are extracted.
Progress · absolute tCO2e
Latest news· last 5 of 13
full news log →- 202490% renewable electricity; on-site solar at new Ohio facility
- 2024Primary: Amgen Ecovation™ electrified biomanufacturing
- 2024TNFD alignment and biodiversity gap analysis
- 2024High-quality Scope 1 carbon offsets augmenting efficiency portfolio
- 2024Dependent: SBTi Scope 3 supplier engagement (73% by spend)